Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erden Eren

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Cell and Developmental Biology|December 11, 2020
Mitochondrial RNA in Alzheimer's Disease Circulating Extracellular VesiclesKyoung Mi Kim, Qiong Meng, Olivia Perez de Acha, et al.
Translational Neurodegeneration|December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse modelCarolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Research Square|July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's diseaseCarolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Journal of Extracellular Vesicles|June 13, 2024
Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVsCarlos J Nogueras-Ortiz, Erden Eren, Pamela Yao, et al.
Molecular Neurodegeneration|January 12, 2019
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathologyMarc Suárez-Calvet, Estrella Morenas-Rodríguez, Gernot Kleinberger, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Cell and Developmental Biology|December 11, 2020
Mitochondrial RNA in Alzheimer's Disease Circulating Extracellular VesiclesKyoung Mi Kim, Qiong Meng, Olivia Perez de Acha, et al.
Translational Neurodegeneration|December 4, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse modelCarolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Research Square|July 28, 2023
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's diseaseCarolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, et al.
Journal of Extracellular Vesicles|June 13, 2024
Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVsCarlos J Nogueras-Ortiz, Erden Eren, Pamela Yao, et al.
Molecular Neurodegeneration|January 12, 2019
Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathologyMarc Suárez-Calvet, Estrella Morenas-Rodríguez, Gernot Kleinberger, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular VolumesLinda J C van Waalwijk van Doorn, Juan D Gispert, H Bea Kuiperij, et al.
Pageof 2